Insphero collaborates with the American Laboratory Products Company

30.07.2018 13:00

Related tags

InSphero’s 3D InSight Diabetes Discovery Platform

Following the receipt of an additional USD 10 million, Insphero has now won American Laboratory Products Company (ALPCO), a leading producer of research and clinical immunoassays as its new partner.

The two companies aim to provide customers with a complete solution to assess beta-cell function in islet microtissue culture models. InSphero’s 3D InSight Diabetes Discovery Platform offers users a comprehensive beta-cell function application suite with all required materials to quantify insulin secretion from 3D InSight Islet Microtissues, including ALPCO’s validated STELLUX Chemiluminescent Insulin ELISA.

InSphero’s 3D InSight platform requires the use of highly sensitive assays that have a broad range and utilize a small sample size to accurately quantify the secretion of insulin and other beta-cell biomarkers from their precious islets,” explains Sean Conley, ALPCO’s president. “Through extensive testing, our STELLUX Chemiluminescent Insulin ELISA proved to meet or exceed the criteria needed for assaying islet microtissue cultures, demonstrating that it is a perfect fit for customers using 3D InSight.”

Burcak Yesildag, InSphero Group Head of Islet Solutions says, “Robust and accurate quantification of insulin secretion from single 3D InSight Islet Microtissues requires a highly sensitive method. We prefer ALPCO’s STELLUXChemiluminescent ELISA because it combines the high sensitivity and broad dynamic range necessary for our model, and requires only a small sample size, thus preserving precious islet material and enabling multi-parametric endpoint analysis.”

ALPCO and InSphero are also currently working to test and validate more STELLUX Chemiluminescent ELISAs to potentially include in the 3D InSight Diabetes Discovery Platform and further promote the advancement of early stage metabolic disease research.

About ALPCO
American Laboratory Products Company (ALPCO) was founded in 1991 as an importer and distributor of immunoassay-based products for the North American life science markets. The company has since grown into a premier channel representing over 60 collaborating partners from around the globe. Today, ALPCO offers a wide range of testing solutions, providing scientists and healthcare professionals with vital tools for advancing research and improving quality of care.

(Press release/ran)

Please login or
register to comment

Please login or sign up to comment. Commenting guidelines

Principal

Partners

Contributors

By continuing to use this website you agree with our TERMS AND CONDITIONS

In order to provide the best quality for you, our system uses "cookies", which are stored on your device. Cookies are necessary to identify what information (job advertisement, questionnaire, etc) you have already seen. IP address is used for the same purposes as described above.

When creating a profile, applying to the newsletter, job subscriptions and etc, you agree that the data, which you have entered, will be stored and processed in the system in order to provide services, which you have applied for.

We do NOT sell your personal data to any 3rd party services.

You must be 18 or older years old to use our services. If you are underage, you must have a permission to use our services from your parent or guardian. It is necessary in order to store and process your data.

By continuing to use our services, you agree with the these terms. You can withdraw your agreement at any time, by deleting cookies from your device and by sending request for deleting your data to the administrator.